Author: Ivan Oransky

Coming soon to a city nowhere near you: The Conference of Universal Rejection

JofURBannerAbout three years ago, we brought Retraction Watch readers news of our new favorite journal, the Journal of Universal Rejection. In a post titled “No retractions necessary” that featured an interview with the editor, Caleb Emmons, we quoted the journal:

The founding principle of the Journal of Universal Rejection (JofUR) is rejection. Universal rejection. That is to say, all submissions, regardless of quality, will be rejected.

So we’re thrilled to learn that the JofUR has now moved into the lucrative conference market, with their Conference of Universal Rejection scheduled for August of this year: Continue reading Coming soon to a city nowhere near you: The Conference of Universal Rejection

Should scientific fraud be treated as a crime?

ori logoSenator Charles Grassley of Iowa — known for his tough questions for the National Institutes of Health (NIH) — wants to know why a former researcher at Iowa State University wasn’t prosecuted more vigorously after he was found to have deliberately spiked rabbit blood samples in a federally-funded HIV vaccine study.

As Tony Leys of the Des Moines Register reports: Continue reading Should scientific fraud be treated as a crime?

Author blames “young coworker” for duplication as paper is retracted

doveDoes anyone know how to say “thrown under the bus” in Italian?

A group of researchers in Italy has retracted a paper after it became clear that they had duplicated some of their previous work. Or, as one of the senior authors put it, as a “young coworker” had reused their material.

Here’s the notice from Biologics: Targets and Therapy: Continue reading Author blames “young coworker” for duplication as paper is retracted

Weekend reads: Seralini GMO-rat study retraction aftershocks; NEJM investigates conflicts of interest

booksAnother busy week at Retraction Watch. Here’s a sampling of items about scientific publishing, research misconduct, and related issues from around the web:
Continue reading Weekend reads: Seralini GMO-rat study retraction aftershocks; NEJM investigates conflicts of interest

Shigeaki Kato up to 23 retractions

katoShigeaki Kato, the former University of Tokyo endocrinology researcher found to have manipulated images in dozens of papers, has six more retractions, bringing his total to 23.

Five of them appear in Molecular and Cellular Biology: Continue reading Shigeaki Kato up to 23 retractions

Faked HIV vaccine research presentation retracted

retrovirologyIn December, we reported on the case of Dong-Pyou Han, who was found by the Office of Research Integrity to have spiked rabbit blood samples to make it look as though a vaccine for HIV was working.

At the time, Han’s former institution, Iowa State, told us that “one oral presentation and some abstracts will be removed from the web.”

One of those retractions has occurred, in Retrovirology, of “Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER.” Here’s the notice: Continue reading Faked HIV vaccine research presentation retracted

Expression of Concern reveals journal editors bending over backward to give authors benefit of the doubt

ceiSometimes, an Expression of Concern says a heck of a lot without — as befits the genre — coming to a particular conclusion. Take this (paywalled)* example describing a paper from a group at Huazhong Science and Technology University, Wuhan, China: Continue reading Expression of Concern reveals journal editors bending over backward to give authors benefit of the doubt

Journal and authors apologize “unreservedly” for distress caused to deceased child’s family by case report

aaicNeuroskeptic featured an interesting situation over the weekend, involving a case report published in an anesthesiology journal.

The case report in Anaesthesia and Intensive Care — about a six-year-old boy with a rare neurological condition who died following administration of anesthesia — caused the boy’s parents great distress when it appeared in November.

Former Hopkins and Pitt cancer researcher notches sixth retraction

GetzenbergRobert Getzenberg, a former researcher at Hopkins and Pitt, has retracted a sixth paper, this one in Cancer Research.

Here’s the notice for “Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology:” Continue reading Former Hopkins and Pitt cancer researcher notches sixth retraction